Cyclin E mRNA overexpression in epithelial ovarian cancers: Inverse correlation with p53 protein accumulation

Journal of the Society for Gynecologic Investigation

Volumn 8, Issue 3, 2001, Pages 179-185

  Sawasaki, Takashi ^a   Shigemasa, Kazushi ^b   Shiroyama, Yuko ^b   Kusuda, Tomoyo ^a   Fujii, Tsuneo ^a   Parmley, Tim H ^c   O'Brien, Timothy J ^c,d   Ohama, Koso ^b  

^a NATIONAL HOSPITAL ORGANIZATION KURE MEDICAL CENTER AND CHUGOKU CANCER CENTER   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cyclin E; Ovarian cancer; Overexpression; p53

Indexed keywords

CYCLIN E; MESSENGER RNA; PROTEIN P53;

ADULT; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMA; CARCINOMA; CYCLIN E; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; OVARY; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUBULIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035010108     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(01)00102-2     Document Type: Article

References (28)

1. G1 phase progression; Cycling on cue
2. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
3. Cell cycle and cancer
4. 1-to-S phase transition
5. Uncoupling of DNA replication and cell cycle progression by human cyclin E
6. Cyclin E, a potential prognostic marker for breast cancer
7. kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
8. Concurrent amplification of cyclin E and Cdk2 genes in colorectal carcinomas
9. Cyclin gene amplification and overexpression in breast and ovarian cancers; Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors
10. Analysis of cyclin E and Cdk2 in ovarian cancer; Gene amplification and RNA overexpression
11. Expression of cyclin E in gynecologic malignancies
12. p53 gene mutation and protein accumulation in human ovarian cancer
13. p53 mutation is a common genetic event in ovarian carcinoma
14. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
15. Alteration of p53 gene in ovarian carcinoma; Clinicopathological correlation and prognostic significance
16. p53 expression, mutation, and allelic deletion in ovarian cancer
17. p53 and K-ras gene mutations in epithelial ovarian neoplasms
18. The role of the p53 tumor-suppressor gene in tumorigenesis
19. p53 cellular tumor antigen; Analysis of mRNA levels in normal adult tissues, embryos and tumors
20. Activating mutations for transformation by p53 produce a gene product that forms a hsc70-p53 complex with an altered half life
21. Cancer statistics
22. Tumors of the ovary and maldeveloped gonads
23. p16 overexpression; A potential early indicator of transformation in ovarian carcinoma
24. p21; A monitor of p53 dysfunction in ovarian neoplasia
25. Cyclin D1 overexpression and p53 mutation status in epithelial ovarian cancer
26. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation
27. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development
28. Long-term cultured IL-2-dependent T cell lines demonstrate p16(INK4a) overexpression, normal pRb/p53, and upregulation of cyclins E or D2